Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 155

1.

Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity.

Pajvani UB, Hawkins M, Combs TP, Rajala MW, Doebber T, Berger JP, Wagner JA, Wu M, Knopps A, Xiang AH, Utzschneider KM, Kahn SE, Olefsky JM, Buchanan TA, Scherer PE.

J Biol Chem. 2004 Mar 26;279(13):12152-62. Epub 2003 Dec 29.

PMID:
14699128
[PubMed - indexed for MEDLINE]
Free Article
2.

Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity.

Pajvani UB, Du X, Combs TP, Berg AH, Rajala MW, Schulthess T, Engel J, Brownlee M, Scherer PE.

J Biol Chem. 2003 Mar 14;278(11):9073-85. Epub 2002 Dec 20.

PMID:
12496257
[PubMed - indexed for MEDLINE]
Free Article
3.

Adiponectin: a relevant player in PPARgamma-agonist-mediated improvements in hepatic insulin sensitivity?

Bouskila M, Pajvani UB, Scherer PE.

Int J Obes (Lond). 2005 Mar;29 Suppl 1:S17-23. Review.

PMID:
15711577
[PubMed - indexed for MEDLINE]
4.

Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways.

Kubota N, Terauchi Y, Kubota T, Kumagai H, Itoh S, Satoh H, Yano W, Ogata H, Tokuyama K, Takamoto I, Mineyama T, Ishikawa M, Moroi M, Sugi K, Yamauchi T, Ueki K, Tobe K, Noda T, Nagai R, Kadowaki T.

J Biol Chem. 2006 Mar 31;281(13):8748-55. Epub 2006 Jan 23.

PMID:
16431926
[PubMed - indexed for MEDLINE]
Free Article
5.

Importance of the high-molecular-mass isoform of adiponectin in improved insulin sensitivity with rosiglitazone treatment in HIV disease.

Qurashi S, Mynarcik DC, McNurlan MA, Ahn H, Ferris R, Gelato MC.

Clin Sci (Lond). 2008 Sep;115(6):197-202. doi: 10.1042/CS20070387.

PMID:
18254722
[PubMed - indexed for MEDLINE]
Free Article
6.

Improved insulin sensitivity and adipose tissue dysregulation after short-term treatment with pioglitazone in non-diabetic, insulin-resistant subjects.

Hammarstedt A, Sopasakis VR, Gogg S, Jansson PA, Smith U.

Diabetologia. 2005 Jan;48(1):96-104. Epub 2004 Dec 29.

PMID:
15624096
[PubMed - indexed for MEDLINE]
7.

Mechanisms of early insulin-sensitizing effects of thiazolidinediones in type 2 diabetes.

Tonelli J, Li W, Kishore P, Pajvani UB, Kwon E, Weaver C, Scherer PE, Hawkins M.

Diabetes. 2004 Jun;53(6):1621-9. Erratum in: Diabetes. 2005 Feb;54(2):587.

PMID:
15161771
[PubMed - indexed for MEDLINE]
Free Article
8.

Thiazolidinediones improve insulin sensitivity in adipose tissue and reduce the hyperlipidaemia without affecting the hyperglycaemia in a transgenic model of type 2 diabetes.

Kim H, Haluzik M, Gavrilova O, Yakar S, Portas J, Sun H, Pajvani UB, Scherer PE, LeRoith D.

Diabetologia. 2004 Dec;47(12):2215-25. Epub 2004 Dec 15.

PMID:
15662559
[PubMed - indexed for MEDLINE]
9.

S26948, a new specific peroxisome proliferator activated receptor gamma modulator improved in vivo hepatic insulin sensitivity in 48 h lipid infused rats.

Sohn KA, Cruciani-Guglielmacci C, Kassis N, Clément L, Ouali F, Caüzac M, Lebègue N, Berthelot P, Caignard DH, Pégorier JP, Renard P, Dacquet C, Ktorza A, Magnan C; Consortium of the French Ministry of Research and Technology.

Eur J Pharmacol. 2009 Apr 17;608(1-3):104-11. doi: 10.1016/j.ejphar.2009.02.033. Epub 2009 Feb 26.

PMID:
19250932
[PubMed - indexed for MEDLINE]
10.

Functional significance of skeletal muscle adiponectin production, changes in animal models of obesity and diabetes, and regulation by rosiglitazone treatment.

Liu Y, Chewchuk S, Lavigne C, Brûlé S, Pilon G, Houde V, Xu A, Marette A, Sweeney G.

Am J Physiol Endocrinol Metab. 2009 Sep;297(3):E657-64. doi: 10.1152/ajpendo.00186.2009. Epub 2009 Jun 16.

PMID:
19531641
[PubMed - indexed for MEDLINE]
Free Article
11.

The potential insulin sensitizing and glucose lowering effects of a novel indole derivative in vitro and in vivo.

Li YY, Wu HS, Tang L, Feng CR, Yu JH, Li Y, Yang YS, Yang B, He QJ.

Pharmacol Res. 2007 Oct;56(4):335-43. Epub 2007 Aug 9.

PMID:
17889553
[PubMed - indexed for MEDLINE]
12.

Post-translational modifications of the four conserved lysine residues within the collagenous domain of adiponectin are required for the formation of its high molecular weight oligomeric complex.

Wang Y, Lam KS, Chan L, Chan KW, Lam JB, Lam MC, Hoo RC, Mak WW, Cooper GJ, Xu A.

J Biol Chem. 2006 Jun 16;281(24):16391-400. Epub 2006 Apr 18.

PMID:
16621799
[PubMed - indexed for MEDLINE]
Free Article
13.

Muraglitazar, a novel dual (alpha/gamma) peroxisome proliferator-activated receptor activator, improves diabetes and other metabolic abnormalities and preserves beta-cell function in db/db mice.

Harrity T, Farrelly D, Tieman A, Chu C, Kunselman L, Gu L, Ponticiello R, Cap M, Qu F, Shao C, Wang W, Zhang H, Fenderson W, Chen S, Devasthale P, Jeon Y, Seethala R, Yang WP, Ren J, Zhou M, Ryono D, Biller S, Mookhtiar KA, Wetterau J, Gregg R, Cheng PT, Hariharan N.

Diabetes. 2006 Jan;55(1):240-8.

PMID:
16380499
[PubMed - indexed for MEDLINE]
Free Article
14.
15.

Selective regulation of cellular and secreted multimeric adiponectin by antidiabetic therapies in humans.

Phillips SA, Kung J, Ciaraldi TP, Choe C, Christiansen L, Mudaliar S, Henry RR.

Am J Physiol Endocrinol Metab. 2009 Sep;297(3):E767-73. doi: 10.1152/ajpendo.00378.2009. Epub 2009 Jul 21.

PMID:
19622782
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

The metabolism of isoforms of human adiponectin: studies in human subjects and in experimental animals.

Peake PW, Kriketos AD, Campbell LV, Shen Y, Charlesworth JA.

Eur J Endocrinol. 2005 Sep;153(3):409-17.

PMID:
16131604
[PubMed - indexed for MEDLINE]
Free Article
17.

Differential regulation of adipocytokine mRNAs by rosiglitazone in db/db mice.

Moore GB, Chapman H, Holder JC, Lister CA, Piercy V, Smith SA, Clapham JC.

Biochem Biophys Res Commun. 2001 Aug 31;286(4):735-41.

PMID:
11520059
[PubMed - indexed for MEDLINE]
18.

Total adiponectin and adiponectin multimeric complexes in relation to weight loss-induced improvements in insulin sensitivity in obese women: the NUGENOB study.

Polak J, Kovacova Z, Holst C, Verdich C, Astrup A, Blaak E, Patel K, Oppert JM, Langin D, Martinez JA, Sørensen TI, Stich V.

Eur J Endocrinol. 2008 Apr;158(4):533-41. doi: 10.1530/EJE-07-0512.

PMID:
18362301
[PubMed - indexed for MEDLINE]
Free Article
19.

Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle.

He W, Barak Y, Hevener A, Olson P, Liao D, Le J, Nelson M, Ong E, Olefsky JM, Evans RM.

Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15712-7. Epub 2003 Dec 5.

PMID:
14660788
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Molecular activation of PPARgamma by angiotensin II type 1-receptor antagonists.

Erbe DV, Gartrell K, Zhang YL, Suri V, Kirincich SJ, Will S, Perreault M, Wang S, Tobin JF.

Vascul Pharmacol. 2006 Sep;45(3):154-62. Epub 2006 May 16.

PMID:
16765099
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk